- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$3.7 BnMarket Estimate, 2026
$3.95 BnMarket Forecast, 2034
$6.59 BnCAGR, 2026–2034
6.63%North America Neurological Monitoring Devices Market Size, Growth, Trends & Forecast (2026–2034)
The North America neurological monitoring devices market size was valued at USD 3.70 billion in 2025, is anticipated to reach USD 3.95 billion in 2026, and is projected to scale up to USD 6.59 billion by 2034, registering a compound annual growth rate (CAGR) of 6.63% during the forecast period from 2026 to 2034. Driven by the commercialization of wearable EEG systems, rising prevalence of neurodegenerative conditions, and an increasing focus on post-surgical cerebrovascular tracking, the regional market continues to expand steadily.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 3.70 Billion
- 2026 Current Valuation: USD 3.95 Billion
- 2034 Forecast Valuation: USD 6.59 Billion
- Compound Annual Growth Rate (CAGR): 6.63% (2026–2034)
- Dominant Procedure Segment: Non-Invasive Procedures (holding the largest share due to user-friendly wearable tech and lower complication risks)
- Dominant Application Segment: Stroke & Traumatic Brain Injuries (accounting for substantial clinical utility in critical care settings)
- Dominant End-User Segment: Hospitals & Specialized Neurological Centers (retaining primary volume shares backed by intensive care infrastructure)
- Dominant Country: The United States (leading the North American regional market with the highest share, followed by Canada)
Core Market Drivers
- Technological Disruption & Wearables: Rapid commercialization of user-friendly, portable, and commoditized EEG monitoring devices.
- Rising Disease Burden: Growing patient demographics suffering from multiple sclerosis, epilepsy, Parkinson's, Alzheimer's, and post-surgical cerebrovascular accidents.
- Expanding Healthcare Awareness: High regional purchasing power coupled with heightened awareness regarding early neurological diagnostics.
Primary Market Restraints & Challenges
- High Equipment Costs: Substantial capital expenses required for advanced monitoring infrastructure and complex diagnostic systems.
- Accessibility & Operation Hurdles: Strict regulatory approval processes and specialized training requirements needed to interpret advanced neuromonitoring outputs.
North America Neurological Monitoring Devices Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (2025 Base) | Fastest-Growing Sub-Segment (2026–2034) |
|---|---|---|
| By Type | Monitors of Brain Electrical Activity (EEG & Evoked Potentials) | Intracranial Pressure & Blood Flow Dynamics (TCD & Tissue Oxygen Monitors) |
| By Procedure | Non-Invasive Procedures (dominant share in outpatient & general screening) | Invasive Procedures (fastest-growing in critical ICU and surgical care monitoring) |
| By Therapeutic Application | Stroke & Traumatic Brain Injuries (major clinical focus areas) | Epilepsy & Dementia (accelerating due to aging populations and home-care trends) |
| By End-User | Hospitals & Neurological Centers (primary revenue generators) | Clinics & Ambulatory Surgical Centers (fastest-growing due to decentralized care) |
| By Country | The United States (market leader holding the highest regional revenue share) | Canada (expanding via healthcare modernization and targeted med-tech investments) |
Major Industry Players Profiled
Key enterprises shaping the competitive North American neurological monitoring devices market include CAS Medical Systems Inc., Compumedics Ltd., Natus Medical Inc., Philips Healthcare, GE Healthcare, AMD Global Telemedicine, Intel Corporation, Johnson & Johnson, InTouch Health, InTechnology, MEG International Services Ltd., Rimed Inc., Siemens Healthcare, Medtronic Inc., Electrical Geodesics Incorporated, Nihon Kohden Corporation, and Advanced Brain Monitoring.
Download Free Sample Report
North America Neurological Monitoring Devices Market Size
The North America Neurological Monitoring Devices Market is projected to grow from USD 3.70 billion in 2025 to USD 3.95 billion in 2026 and reach USD 6.59 billion by 2034, registering a CAGR of 6.63% from 2026 to 2034.
Due to the advent of wearable medical devices, the greatest shifting trend is observed in the commercialization and commoditization of EEG devices. Manufacturers are introducing disruptive devices that can be used and interpreted easily by a user, which is a growing awareness of neurological disorders at an unprecedented level.
The North American region offers an enormous untapped market for it because of increasing awareness of neurological disorders, a rise in purchasing power, and an increasing number of people with multiple sclerosis, epilepsy, cerebrovascular diseases, Parkinson’s, and Alzheimer’s diseases. Increases in the prevalence of post-surgical cerebrovascular accidents have triggered the need for more improved and automated devices. The high cost of devices is majorly restraining market growth.
MARKET SEGMENTATION
This report has been segmented and sub-segmented the North American Neurological Monitoring Devices Market into the following categories
North America Neurological Monitoring Devices Market - By Type
-
Monitors of Intracranial Pressure & Blood Flow Dynamics
-
Intracranial Pressure Monitor
- Jugular Venous Oximetry
- Transcranial Doppler (TCD) Ultrasonography
- Near-Infrared Spectroscopy
- Brain Tissue Oxygen Tension Monitor
- Monitors of Brain Electrical Activity
- Electroencephalography
- Evoked Potentials
North America Neurological Monitoring Devices Market - By Procedure
-
Non-Invasive
-
Invasive
North America Neurological Monitoring Devices Market - By Therapeutic Application
-
Traumatic Brain Injuries
-
Stroke
- Dementia
- Headache Disorders
- Sleep Disorders
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
North America Neurological Monitoring Devices Market - By End-Users
-
Hospitals
-
Neurological Centers and Institutions
- Clinics & Ambulatory Surgical Centers
- Diagnostic Centers
- Ambulances
North America Neurological Monitoring Devices Market - By Country
-
The United States
-
Canada
- Rest of North America
Regionally, the USA is leading the market with the highest number of shares, followed by Canada.
KEY MARKET PLAYERS
Key market players include CAS Medical Systems Inc., Compumedics Ltd., Natus Medical Inc., Philips Healthcare, GE Healthcare, AMD Global Telemedicine, Intel Corporation, Johnson & Johnson, InTouch Health, InTechnology, MEG International Services Ltd., Rimed Inc., Siemens Healthcare, Medtronic Inc., Electrical Geodesics Incorporated, Nihon Kohden Corporation, and Advanced Brain Monitoring.